Analysis on the Hospitalization Costs of 274 Postmenopausal Patients with Hysteromyoma
Objectives To select hospitalization data of postmenopausal uterine fibroids patients from a certain hospital in Beijing,analyze their cost level,cost structure,and influencing factors,and provide a basis for reasonable cost control and reducing the patient's costs burden.Methods The study included hospitalized cases of postmenopausal uterine fibroids from June 15th,2019 to December 31st,2022.The level and structure of hospitalization costs were analyzed through general description and constituent ratio analysis.The influencing factors of hospitalization costs for this disease were analyzed using one-way ANOVA and multiple linear regression statistical methods.Results Among 274 patients,the average length of stay was 6 days,and the average hospitalization cost was 14077.34 yuan per visit.Among them,surgical anesthesia cost accounted for the highest proportion(30.82％),material cost accounted for the second(23.94％),drug cost accounted for the third(14.89％),laboratory cost accounted for the fourth(10.07％),and examination and treatment cost accounted for the fifth(8.12％).Through one-way ANOVA and multiple linear regression analysis,it was found that factors such as hospitalization days,intraoperative bleeding,number of surgeries,and surgical methods have a significant impact on hospitalization costs.The longer the hospitalization days,the more surgeries,and the more intraoperative bleeding,the higher the total cost;The total cost of hysteroscopic surgery was significantly lower than the total cost of laparoscopic,combined abdominal,and open surgery.Conclusions The hospitalization costs for postmenopausal patients with uterine fibroids had increased,with a reduction of 1.22±0.12 days in length.The main costs include material costs,surgical costs,medication costs,and testing costs.Among them,hospitalization days,intraoperative bleeding,number of surgeries,and surgical methods were the main factors that affected hospitalization costs.It was recommended to deepen clinical pathways to standardize medical behavior,optimize cost structure,reduce ineffective hospitalization days,and further reduce the costs burden on elderly female patients.
NETL
NSTL
万方数据
